fashion -WSS

fashion

author：entertainment 2025-09-03 12:10:41 - browse：7857

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： A disappointing year of Humira biosimilars

WSS

Private equity deals in Medicare Advantage declines

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

STAT Virtual Event: How to Increase Diversity in Clinical Trials

FDA advisers vote against ALS treatment from BrainStorm

Would Medicare drug price negotiations stall in a shutdown?

Medicare Advantage proposed rates disappoint insurers

Wikipedia

fashion

entertainment

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: How biotech is using artificial intelligence

Dobbs anniversary: the lost opportunity of abortion as health care

For Medicare Advantage, Democrats want stronger protections around AI

Moonlake's readout produced a cash windfall. Risks remain

Ionis has late

Supreme Court strikes down use of affirmative action

Key House Republican on health care plans exit from Congress

Novavax promises a turnaround & Lilly roils the obesity market

How the Dana

hotspot

KalVista pill reduced swelling 'attacks' caused by genetic disease

Why did Pfizer dish out millions for a Super Bowl ad?

Kaiser Permanente unions announce official strike date

Listen: Who gets the credit for GLP

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Did you have Obamacare on your GOP debate bingo card?

explore

knowledge

explore

leisure time